Antibody Discovery News and Research

RSS

Dotmatics Biology Solution for Antibody Discovery streamlines data collection and workflows to accelerate antibody research and therapies

...

From Dotmatics 5 May 2022

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Researchers isolate three mAbs that broadly neutralized sarbecoviruses and carried out virological and structural studies of these mAbs.

21 Apr 2022

Fortis Life Sciences acquires Abcore, a leader in nanobody technologies

Fortis Life Sciences has acquired Abcore, a San Diego, California, USA based antibody discovery platform specializing in nanobody technology. With the addition of Abcore, Fortis extends its capabilities into the antibody discovery market serving biopharma customers developing antibody and nanobody-based therapeutics.

From Fortis Life Sciences 3 Mar 2022

New cryo-EM method may be able to shortcut a big step in modern vaccine development

Scientists at Scripps Research have devised a method that may be able to shortcut one of the big steps in modern vaccine development.

20 Jan 2022

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

A new study discusses the targeted discovery of NTD-reactive antibodies from an individual who had recovered from SARS-CoV-2 infection.

19 Jan 2022

Production of molecular probes of spike and subdomains for all SARS-CoV-2 variants

Researchers designed molecular probes of diverse SARS-CoV-2 variants and evaluated their antibody binding specificity.

3 Jan 2022

The use of monoclonal antibodies against infectious pathogens

Joshua Tan of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health wrote a review article in the journal DNA and Cell Biology about the role of monoclonal antibodies and briefly described a study on bispecific antibodies that neutralize SARS-CoV-2.

30 Dec 2021

Sartorius strengthens its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions

The life science group Sartorius is expanding its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions GmbH.

From Sartorius 16 Dec 2021

Systematic survey of human SARS-CoV-2 monoclonal antibodies

Scientists have mined information from several research publications and patents to create a dataset of approximately 8000 human antibodies to the SARS-CoV-2 spike from more than 200 donors.

2 Dec 2021

Scientists develop a high-throughput, cell-free screening platform for anti-SARS-CoV-2 antibody discovery

Scientists from Northwestern University, USA, have recently developed a high-throughput, automated screening platform to rapidly identify anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. The study is currently available on the bioRxiv* preprint server.

8 Nov 2021

Unexpected antibody discovery provides new insight into how the body responds to malaria infection

Malaria, a pathogen transmitted into blood by mosquitoes in tropical climates, is typically thought of as a blood and liver infection.

3 Nov 2021

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

In an article published in the open-access journal Advance Engineering, a multinational team of researchers reported the selection and characterization of 3 potent SARS-CoV-2 antibodies - S-E6, S-B8, and S-D4 - from a pre-COVID-19 human combinatorial antibody library that was established 20 years ago.

3 Nov 2021

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Sphere Fluidics announced today that it has closed a $40 million (circa £30 million) investment round.

From Fluidic Sciences and Sphere Bio 28 Oct 2021

Antibody validation and rapid peptide mapping technology

In this interview, News-Medical speaks to Bin Ma, President of Rapid Novor, about antibody validation and rapid peptide mapping technology.

From Rapid Novor Inc 11 Oct 2021

Using a new public antibody to understand SARS-CoV-2 neutralization

SARS-CoV-2 infects host cells by binding to the angiotensin convertase 2 receptor (ACE2) on the cell surface through its trimeric spike (S) protein. SARS-CoV enters host human cells through endosomes, while SARS-CoV-2 enters through the cell surface and endosomes. The present study published in the journal “Cell Reports” aimed to understand the mechanisms of SARS-CoV-2 antibody neutralization to facilitate the development of therapeutic interventions for COVID-19.

4 Oct 2021

Antibody Discovery News and Research

Dotmatics Biology Solution for Antibody Discovery streamlines data collection and workflows to accelerate antibody research and therapies

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Fortis Life Sciences acquires Abcore, a leader in nanobody technologies

New cryo-EM method may be able to shortcut a big step in modern vaccine development

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

Production of molecular probes of spike and subdomains for all SARS-CoV-2 variants

The use of monoclonal antibodies against infectious pathogens

Sartorius strengthens its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions

Systematic survey of human SARS-CoV-2 monoclonal antibodies

Scientists develop a high-throughput, cell-free screening platform for anti-SARS-CoV-2 antibody discovery

Unexpected antibody discovery provides new insight into how the body responds to malaria infection

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group

Antibody validation and rapid peptide mapping technology

Using a new public antibody to understand SARS-CoV-2 neutralization

A World First: sequencing polyclonal antibodies using only proteomics

Researchers develop rapid antibody screening method for novel COVID-19 therapeutics development

Rapid Novor First to Decode Polyclonal Antibodies Using Only Proteomics

Potent antibody with unique genetic signature and spike recognition mechanism neutralizes SARS-CoV-2

Sphere Fluidics announces enhanced Cyto-Mine capability and performance

Accelerating therapeutic antibody discovery and development eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News